Xue-Yuan Bai (Xueyuan Bai)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Venues

Cell death discovery

BioMed research international

Mediators of inflammation

Cell death & disease

Chinese PLA General Hospital

Chinese Academy of Military Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chinese PLA General Hospital Aug 01 1999

China

Professor :: Department of Nephrology, State Key Laboratory of Kidney Diseases

Education History

Chinese Academy of Military Medical Sciences Aug 01 1996 - Aug 01 1999

China

PHD :: Department of Medical Immunology

Publications

Yi Ren, Shaoyuan Cui, Quan Hong, Wanjun Shen, Qinggang Li, Lingling Wu, Bo Fu, Xu Wang, Qian Ma, Jiaona Liu, Xue-Yuan Bai, Xiang-Mei Chen
Role of NOD-Like Receptors in a Miniature Pig Model of Diabetic Renal Injuries. Mediators of inflammation 2022 (2022)
Guangrui Geng, Yunming Xiao, Yingjie Zhang, Wanjun Shen, Jiaona Liu, Fei Zhu, Xu Wang, Jie Wu, Ran Liu, Guang-Yan Cai, Xue-Yuan Bai, Qinggang Li, Xiang-Mei Chen
Ganab Haploinsufficiency Does Not Cause Polycystic Kidney Disease or Polycystic Liver Disease in Mice. BioMed research international 2020 (2020)
Luchan Deng, Hongling Li, Xiaodong Su, Yingjie Zhang, Haoying Xu, Linyuan Fan, Junfen Fan, Qin Han, Xue-Yuan Bai, Robert Chunhua Zhao
Chlorzoxazone, a small molecule drug, augments immunosuppressive capacity of mesenchymal stem cells via modulation of FOXO3 phosphorylation. Cell death & disease 11 (3) (2020)
Jing Zhao, Yuxiang Ma, Yingjie Zhang, Bo Fu, Xiaoyuan Wu, Qinggang Li, Guangyan Cai, Xiangmei Chen, Xue-Yuan Bai
Low-dose 2-deoxyglucose and metformin synergically inhibit proliferation of human polycystic kidney cells by modulating glucose metabolism. Cell death discovery 5 (2019)
Xiaoying Lian, Xiaoyuan Wu, Zhongxin Li, Yingjie Zhang, Kangkang Song, Guangyan Cai, Qinggang Li, Shupeng Lin, Xiangmei Chen, Xue-Yuan Bai
The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease. British journal of pharmacology 176 (5) (2019)
Fengge Zhu, Xue-Yuan Bai, Quan Hong, Shaoyuan Cui, Xu Wang, Fengjun Xiao, Jin Li, Li Zhang, Zhe-Yi Dong, Yong Wang, Guangyan Cai, Xiangmei Chen
STAT3 Inhibition Partly Abolishes IL-33-Induced Bone Marrow-Derived Monocyte Phenotypic Transition into Fibroblast Precursor and Alleviates Experimental Renal Interstitial Fibrosis. Journal of immunology (Baltimore, Md. : 1950) 203 (10) (2019)

Xue-Yuan Bai.css-eqlu8i{font-size:small;padding-left:4px;} (Xueyuan Bai)

Publication Activity (10 Years)

Top Topics

Top Venues

Xue-Yuan Bai (Xueyuan Bai)